# A Safety Study in Healthy Volunteers of the Single-Use Autoinjector Containing Placebo of BG9418 Interferon Beta-1a With a 25-Gauge × 1-Inch Needle

> **NCT01313364** · PHASE1 · TERMINATED · sponsor: **Biogen** · enrollment: 80 (actual)

## Conditions studied

- Healthy

## Interventions

- **DEVICE:** 25G x 1" Needle Autoinjector

## Key facts

- **NCT ID:** NCT01313364
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-03
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 80 (ACTUAL)
- **Why stopped:** The objective of the study has been achieved with fewer subjects than planned.
- **Last updated:** 2011-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01313364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01313364, "A Safety Study in Healthy Volunteers of the Single-Use Autoinjector Containing Placebo of BG9418 Interferon Beta-1a With a 25-Gauge × 1-Inch Needle". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01313364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*